Eluxadoline: what it treats, how to take it, side effects
Last updated September 3, 2026.
Eluxadoline is a mu-opioid receptor agonist - it slows bowel activity by acting on opioid receptors in the gut. You may know it as Viberzi. For IBS-D - the irritable bowel syndrome where diarrhea runs the day.
What does it treat?
Irritable bowel syndrome with diarrhea in adults: the stomach pain, cramping, and loose or watery stools.
How do you take it?
Twice daily with food, same times every day - exactly as directed. Missed dose: take it when you remember, with food - unless the next one is close; never double up.
Side effects to know
- Common: nausea, vomiting, constipation, dizziness, tiredness.
- Serious - stop taking it and call your doctor immediately: pain that begins in the upper stomach area and may spread to the back or shoulder, with or without nausea and vomiting - the pancreas-and-bile warning, worth knowing cold. Alcohol raises that risk: the safe-use conversation is part of starting.
Who should not take it?
The gate list is specific: no gallbladder, bile-duct obstruction, sphincter of Oddi problems, intestinal blockage, pancreatitis history, liver disease, heavy alcohol use - more than 3 drinks a day - or frequent constipation: these usually rule it out entirely. Alcohol on the drug raises pancreatitis risk. If you become pregnant, call your doctor.
When is it an emergency?
Severe upper-stomach pain spreading to the back or shoulder - especially with vomiting - is urgent care now. For an overdose, call Poison Control at 1-800-222-1222. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
What is the stomach-pain warning?
The pattern to know cold: pain beginning in the upper stomach area, possibly spreading to the back or shoulder, with or without nausea and vomiting - pancreas-and-bile territory on this drug. The instruction is specific: stop taking eluxadoline and call your doctor immediately or get emergency care. It is the reason the gallbladder, bile-duct, and alcohol questions come before the first dose.
Why did they ask about my gallbladder and alcohol?
The gate list: no gallbladder, bile-duct obstruction, sphincter of Oddi problems, intestinal blockage, pancreatitis history, liver disease, heavy alcohol use - more than 3 drinks a day - or frequent constipation usually rule the drug out entirely: its mechanism touches the bile plumbing. Alcohol on the drug raises the pancreatitis risk - the safe-use conversation is part of starting, and for many patients the answer is zero.
How does it calm the diarrhea?
Targeted opioid action: the drug acts on mu-opioid receptors in the gut - slowing the overactive bowel - designed to stay mostly out of the brain. It treats the pain and the urgency together, because they run on the same overactivity. It controls the condition; it does not cure it - the diet and trigger work still run alongside.
What are the common side effects?
Nausea, vomiting, constipation, dizziness, tiredness - the slowdown trade-offs. Constipation deserves the early mention: it is the mechanism overshooting, and persistent or severe constipation is a doctor conversation, not a fiber improvisation. The severe stomach-pain pattern is in a different category - stop and call, immediately.
Why twice a day with food?
Steady coverage: the bowel runs all day, so the drug does too - breakfast and dinner anchors, with food for tolerability. The missed-dose rule matches: remembered with food, unless the next dose is close - never double up. The routine is the treatment's steady state; erratic timing shows up as erratic days.
What happens if I miss a dose of eluxadoline?
Take it as soon as you remember, with food - unless it is almost time for the next one: then skip it and never double up. One missed dose often means a looser afternoon - the condition peeking through - then the rhythm resumes. Misses that cluster mean the anchor needs redesigning: the tablets live where you eat.
